Of the 9524 white subjects examined, 3.2% had a sequence variation in PCSK9 that was associated with a 15% reduction in LDL cholesterol and a significant 47% reduction in the risk of ischaemic heart disease. The gene discussed is PCSK9; the disease is heart disorder.